Is there any clinical parameter able to predict prostate cancer after initial diagnosis of atypical small acinar proliferation?

Urol Int. 2008;81(1):29-35. doi: 10.1159/000137637. Epub 2008 Jul 16.

Abstract

Introduction: Tissue samples from prostate biopsy may contain atypical small acinar proliferation (ASAP): present guidelines recommend a repeat biopsy policy. This study attempted to identify clinical patterns that help predict cancer detection at second biopsy.

Materials and methods: From 1999 to 2005, 1,274 patients underwent a prostate biopsy: in 5.9% ASAP was found, and patients underwent a second biopsy. Uni- and multivariate analysis compared the clinical patterns of cancer patients with the no cancer group at second biopsy.

Results: Univariate analysis showed significant differences in PSA ratio density, prostate volume, final PSA values and Delta PSA; at multivariate logistic regression analysis, only PSA ratio (OR = 0.743, 95% CI 0.620-0.891) and prostate volume (OR = 0.960, 95% CI 0.924-0.998) were predictive of malignancy.

Conclusions: In our experience, PSA ratio and prostate volume seem to be independent predictors of prostate cancer at re-biopsy.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Biopsy
  • Cell Proliferation*
  • Humans
  • Male
  • Medical Oncology / methods
  • Middle Aged
  • Multivariate Analysis
  • Predictive Value of Tests
  • Prostate-Specific Antigen / biosynthesis
  • Prostatic Neoplasms / diagnosis*
  • Prostatic Neoplasms / pathology*
  • ROC Curve
  • Regression Analysis
  • Sensitivity and Specificity

Substances

  • Prostate-Specific Antigen